Antibody-based imaging strategies for cancer CANCER AND METASTASIS REVIEWS Warram, J. M., de Boer, E., Sorace, A. G., Chung, T. K., Kim, H., Pleijhuis, R. G., van Dam, G. M., Rosenthal, E. L. 2014; 33 (2-3): 809-822


Although mainly developed for preclinical research and therapeutic use, antibodies have high antigen specificity, which can be used as a courier to selectively deliver a diagnostic probe or therapeutic agent to cancer. It is generally accepted that the optimal antigen for imaging will depend on both the expression in the tumor relative to normal tissue and the homogeneity of expression throughout the tumor mass and between patients. For the purpose of diagnostic imaging, novel antibodies can be developed to target antigens for disease detection, or current FDA-approved antibodies can be repurposed with the covalent addition of an imaging probe. Reuse of therapeutic antibodies for diagnostic purposes reduces translational costs since the safety profile of the antibody is well defined and the agent is already available under conditions suitable for human use. In this review, we will explore a wide range of antibodies and imaging modalities that are being translated to the clinic for cancer identification and surgical treatment.

View details for DOI 10.1007/s10555-014-9505-5

View details for Web of Science ID 000339879100030

View details for PubMedID 24913898

View details for PubMedCentralID PMC4116453